MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Venture Capital: Risk Capital_Angel, Venture, Sovereign Wealth Investor Companies & Organizations
*Portfolio Companies: Domain
OraPharma, Inc
Parents
*Portfolio Companies: Domain
Architects: Dental, Oral, Craniofacial Companies
Companies: Acquired_(M&A)
Finance & Acquisition: Johnson & Johnson (J&J)
Children
Acquired by Johnson & Johnson
Founded 1996
In addition, OraPharma, Inc. distributes HEALOS® (Bone Graft Substitute for Dental Applications) is intended to fill, augment, or reconstruct periodontal and or bony defects of the upper or lower jaw.
OraPharma, Inc.'s lead product, ARESTIN® (minocycline hydrochloride) Microspheres, 1 mg, is indicated as an adjunct to scaling and root planing (SRP) procedures for the reduction of pocket depth in patients with adult periodontitis.